John H. Shares Rectal Cancer Journey and Complete Clinical Response After Immunotherapy

John H. Shares Rectal Cancer Journey and Complete Clinical Response After Immunotherapy

Colorectal Cancer Alliance shared on LinkedIn:

“‘In February, I was diagnosed with stage III rectal cancer – definitely not on the year’s to-do list.

My cancer was dMMR/MSI-H, which opened the door to immunotherapy with nivolumab and ipilimumab. After treatment, scans, scopes, and more people seeing my backside than is socially acceptable, by June I was cancer-free – 100% clinical response, with no trace of the tumour.

One thing I’ve kept doing throughout all of this is exercise every day. Walking the dogs, getting my steps in and rebuilding my fitness. It gives me something positive I can control and has been massively important for me, physically and mentally.

I’m still having treatment and regular watch-and-wait surveillance. Immunotherapy also gave me adrenal insufficiency, so my adrenal glands have taken early retirement, and genetic testing added Lynch syndrome (MSH2) to the story too.

So I keep turning up and keep moving.’ – John H.

John H.

Need support along the way?

Give us a call on our free helpline at 877-422-2030 and speak to a member of our Cancer Care Team.

Thank you to Takeda Oncology for supporting the Alliance’s Cancer Care services.”